• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下和舌下免疫疗法治疗儿童过敏性哮喘的疗效评估与比较

Evaluation and Comparison of the Efficacy of Subcutaneous and Sublingual Immunotherapy for the Treatment of Allergic Asthma in Children.

作者信息

Berce Vojko, Cugmas Maša, Čopi Staša, Koren Brigita, Tomazin Maja, Hojnik Tina

机构信息

Department of Pediatrics, University Medical Centre Maribor, Ljubljanska Ulica 5, 2000 Maribor, Slovenia.

Pediatrija Šentilj Outpatient Clinic, Pod Hribom 14, 2212 Municipality of Sentilj, Slovenia.

出版信息

Children (Basel). 2024 Jun 5;11(6):692. doi: 10.3390/children11060692.

DOI:10.3390/children11060692
PMID:38929271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11201833/
Abstract

Specific immunotherapy represents the only potentially curative treatment for allergic asthma. Allergens can be administered subcutaneously (SCIT) or sublingually (SLIT). The aim of the current study was to evaluate and compare the efficacy of SCIT and SLIT for the treatment of allergic asthma in children. Our study included 69 children with allergic asthma who underwent immunotherapy for house dust mites or pollen for at least 3 consecutive years. After 3 years of SCIT and SLIT, the median number of asthma exacerbations in the last three months decreased from 2 to 0 ( < 0.01) and from 1 to 0 ( < 0.01), respectively. When comparing the efficacy of SCIT and SLIT, our study revealed a significantly better efficacy of SCIT only in terms of increasing lung function. The median increase in forced expiratory volume in one second (FEV1) after 3 years was 8% with SCIT and -1% with SLIT ( < 0.01). Daily controller therapy could be withdrawn or reduced in 9 out of 16 (56.3%) children who received it before SCIT ( < 0.01) and in 19 of 29 (65.6%) children who received it before SLIT ( < 0.01), but the difference in efficacy was not significant ( = 0.88). Both SCIT and SLIT are effective treatments for allergic asthma in children.

摘要

特异性免疫疗法是过敏性哮喘唯一可能的治愈性治疗方法。变应原可通过皮下注射(皮下免疫疗法)或舌下含服(舌下免疫疗法)给药。本研究的目的是评估和比较皮下免疫疗法和舌下免疫疗法治疗儿童过敏性哮喘的疗效。我们的研究纳入了69名患有过敏性哮喘的儿童,他们接受了针对屋尘螨或花粉的免疫疗法,且连续至少3年。经过3年的皮下免疫疗法和舌下免疫疗法后,过去三个月哮喘发作的中位数分别从2次降至0次(<0.01)和从1次降至0次(<0.01)。在比较皮下免疫疗法和舌下免疫疗法的疗效时,我们的研究发现仅在增加肺功能方面皮下免疫疗法的疗效明显更好。3年后,皮下免疫疗法组一秒用力呼气量(FEV1)的中位数增加了8%,舌下免疫疗法组增加了-1%(<0.01)。在接受皮下免疫疗法前接受每日控制治疗的16名儿童中有9名(56.3%)(<0.01)以及在接受舌下免疫疗法前接受每日控制治疗的29名儿童中有19名(65.6%)(<0.01)可以停用或减少每日控制治疗,但疗效差异不显著(=0.88)。皮下免疫疗法和舌下免疫疗法都是治疗儿童过敏性哮喘的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f27/11201833/890938122f8c/children-11-00692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f27/11201833/890938122f8c/children-11-00692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f27/11201833/890938122f8c/children-11-00692-g001.jpg

相似文献

1
Evaluation and Comparison of the Efficacy of Subcutaneous and Sublingual Immunotherapy for the Treatment of Allergic Asthma in Children.皮下和舌下免疫疗法治疗儿童过敏性哮喘的疗效评估与比较
Children (Basel). 2024 Jun 5;11(6):692. doi: 10.3390/children11060692.
2
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).IgE介导的过敏性疾病中变应原特异性免疫治疗指南:德国变态反应学与临床免疫学会(DGAKI)、儿科变态反应与环境医学学会(GPA)、德国变态反应科医生医学协会(AeDA)、奥地利变态反应与免疫学会(ÖGAI)、瑞士变态反应与免疫学会(SGAI)、德国皮肤病学会(DDG)、德国耳鼻咽喉头颈外科学会(DGHNO-KHC)、德国儿科学与青少年医学学会(DGKJ)、儿科肺病学会(GPP)、德国呼吸学会(DGP)、德国耳鼻喉外科医生协会(BV-HNO)、儿科医生与青年医生专业联合会(BVKJ)、肺科医生联邦协会(BDP)以及德国皮肤科医生协会(BVDD)的S2k指南
Allergo J Int. 2014;23(8):282-319. doi: 10.1007/s40629-014-0032-2.
3
Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.舌下免疫治疗与皮下免疫治疗在儿童变应性鼻炎中的疗效和安全性:系统评价和荟萃分析。
Front Immunol. 2023 Dec 15;14:1274241. doi: 10.3389/fimmu.2023.1274241. eCollection 2023.
4
Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.皮下免疫疗法抑制 Th2 炎症并诱导中和抗体,而舌下免疫疗法抑制草花粉变应性哮喘小鼠模型中的气道高反应性。
Clin Exp Allergy. 2018 Aug;48(8):1035-1049. doi: 10.1111/cea.13169. Epub 2018 Jun 8.
5
Changes in CD4+CD25+FoxP3+ Regulatory T Cells and Serum Cytokines in Sublingual and Subcutaneous Immunotherapy in Allergic Rhinitis with or without Asthma.变应性鼻炎伴或不伴哮喘患者舌下和皮下免疫治疗中CD4+CD25+FoxP3+调节性T细胞及血清细胞因子的变化
Int Arch Allergy Immunol. 2020;181(1):71-80. doi: 10.1159/000503143. Epub 2019 Nov 13.
6
Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy.螨虫单一过敏患儿行皮下免疫和舌下免疫治疗后 2 年的临床和炎症参数随访。
Asian Pac J Allergy Immunol. 2013 Sep;31(3):233-41. doi: 10.12932/AP0276.31.3.2013.
7
An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.基于证据的室内尘螨变应原免疫治疗分析:呼吁开展更严格的临床研究。
J Allergy Clin Immunol. 2013 Dec;132(6):1322-36. doi: 10.1016/j.jaci.2013.09.004. Epub 2013 Oct 18.
8
House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.屋尘螨舌下免疫治疗小儿变应性哮喘。
Ann Pharmacother. 2018 Oct;52(10):1019-1030. doi: 10.1177/1060028018769443. Epub 2018 Apr 11.
9
Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.丹麦针对屋尘螨呼吸道过敏性疾病的舌下免疫疗法与皮下免疫疗法的成本最小化分析。
J Med Econ. 2016 Aug;19(8):735-41. doi: 10.3111/13696998.2016.1158718. Epub 2016 Mar 16.
10
Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison.皮下免疫治疗和舌下免疫治疗尘螨变应性的疗效:基于网状Meta 分析的比较。
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4450-4458.e6. doi: 10.1016/j.jaip.2021.08.018. Epub 2021 Aug 28.

本文引用的文献

1
Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.舌下免疫治疗与皮下免疫治疗在儿童变应性鼻炎中的疗效和安全性:系统评价和荟萃分析。
Front Immunol. 2023 Dec 15;14:1274241. doi: 10.3389/fimmu.2023.1274241. eCollection 2023.
2
Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma.与哮喘患者中屋尘螨舌下免疫疗法疗效相关的基因和2型生物标志物。
Thorax. 2024 Mar 15;79(4):332-339. doi: 10.1136/thorax-2023-220707.
3
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
量化儿童早期舌下过敏原免疫治疗片起始治疗的获益。
Allergy. 2024 Apr;79(4):1018-1027. doi: 10.1111/all.15985. Epub 2023 Dec 26.
4
Efficacy of Sublingual Immunotherapy in Allergic Rhinitis Patients with Asthma: A Systematic Review and Meta-Analysis.舌下免疫疗法治疗哮喘伴变应性鼻炎患者的疗效:系统评价和荟萃分析。
Am J Rhinol Allergy. 2023 Nov;37(6):766-776. doi: 10.1177/19458924231193528. Epub 2023 Aug 9.
5
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.变应原免疫治疗在变应性哮喘中应用的临床结局的标准化:一项 EAACI 立场文件。
Allergy. 2023 Nov;78(11):2835-2850. doi: 10.1111/all.15817. Epub 2023 Jul 14.
6
Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study. rush-皮下和舌下免疫疗法与屋尘螨提取物治疗儿童变应性鼻炎的比较:一项前瞻性队列研究。
Allergol Int. 2023 Oct;72(4):573-579. doi: 10.1016/j.alit.2023.02.007. Epub 2023 Mar 12.
7
Allergen immunotherapy for allergic asthma: The future seems bright.变应原免疫治疗变应性哮喘:前景光明。
Respir Med. 2023 Apr-May;210:107125. doi: 10.1016/j.rmed.2023.107125. Epub 2023 Jan 24.
8
Efficacy and safety of sublingual allergen immunotherapy.舌下过敏原免疫治疗的疗效和安全性。
Allergy Asthma Proc. 2022 Jul 1;43(4):272-280. doi: 10.2500/aap.2022.43.220036.
9
Immunotherapy for Asthma.哮喘免疫疗法。
Semin Respir Crit Care Med. 2022 Oct;43(5):709-719. doi: 10.1055/s-0042-1749454. Epub 2022 Jun 17.
10
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis.鼻一氧化氮和鼻细胞学作为预测儿童变应性鼻炎短期舌下变应原特异性免疫治疗疗效的指标。
Am J Rhinol Allergy. 2022 May;36(3):323-329. doi: 10.1177/19458924211060592. Epub 2021 Dec 6.